You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Chlorotrianisene

Showing 1 - 25 of 43
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hepatocellular Carcinoma Trial (TACE+Camrelizumab+Apatinib mesylate, TACE)

Recruiting
  • Hepatocellular Carcinoma
  • TACE+Camrelizumab+Apatinib mesylate
  • TACE
  • Shanghai, Shanghai, China
    Zhongshan Hospital, Fudan University
Oct 17, 2022

Hepatocellular Carcinoma Non-resectable Trial in Guangzhou (Sin-Bev-TACE, Len-TACE)

Recruiting
  • Hepatocellular Carcinoma Non-resectable
  • Guangzhou, Guangdong, China
    the Second Affiliated Hospital of Guangzhou Medical University
Aug 2, 2023

Melanoma Neuroendocrine Tumors Neuroectodermal Tumors Tumors Germ Cell and Embryonal Tumors by Histologic Type Tumors Tumors

Not yet recruiting
  • Melanoma Neuroendocrine Tumors Neuroectodermal Tumors Neoplasms Germ Cell and Embryonal Neoplasms by Histologic Type Neoplasms Neoplasms
  • HX008 + TACE
  • +2 more
  • Beijing, Beijing, China
    Beijing Cancer hospital
Dec 8, 2022

Hepatocellular Carcinoma, Liver Cancer Trial in Seoul (IDA-TACE, DOX-TACE)

Recruiting
  • Hepatocellular Carcinoma
  • Liver Cancer
  • IDA-TACE
  • DOX-TACE
  • Seoul, Korea, Republic of
    Seoul National University Hospital
Oct 27, 2023

TACE-HAIC Combined With TKIs and Immunotherapy Versus TACE Alone

Completed
  • Hepatocellular Carcinoma
  • TACE-HAIC
  • +3 more
  • GuangZhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Sep 8, 2022

Hepatocellular Carcinoma, Immunotherapy, Preoperative Trial in Nanjing (Camrelizumab, Apatinib Mesylate, Postoperative TACE

Recruiting
  • Hepatocellular Carcinoma
  • +2 more
  • Nanjing, Jiangsu, China
    Jiangsu Province Hospital
Nov 6, 2022

HCC Trial in Pisa (Microwave ablation + Occlusafe + DEB-TACE, Microwave ablation + Occlusafe, Microwave ablation + DEB-TACE)

Recruiting
  • HCC
  • Microwave ablation + Occlusafe + DEB-TACE
  • +2 more
  • Pisa, Italy
    Azienda Ospedaliero-Universitaria Pisana
Oct 21, 2022

HCC Trial in China (DEB-TACE and HAIC, DEB-TACE)

Recruiting
  • HCC
  • DEB-TACE and HAIC
  • DEB-TACE
  • Luohe, Henan, China
  • +15 more
Mar 28, 2023

Hepatocellular Carcinoma Trial in France (TACE, TACE+ RTC)

Completed
  • Hepatocellular Carcinoma
  • TACE
  • TACE+ RTC
  • Amiens, France
  • +17 more
Dec 23, 2021

Radiofrequency-assisted Liver Resection in Intractable Liver

Completed
  • Liver Cancer
  • radiofrequency
  • +2 more
  • Lanzhou, Gansu, China
    Hepatopancreatobiliary Surgery Institute of Gansu Province
Nov 18, 2021

Hepatocellular Carcinoma Trial in Shanghai (TACE combined with Camrelizumab, TACE plus Camrelizumab)

Enrolling by invitation
  • Hepatocellular Carcinoma
  • TACE combined with Camrelizumab
  • TACE plus Camrelizumab
  • Shanghai, Shanghai, China
    Department of Interventional Radiology, Zhongshan Hospital, Fuda
Sep 23, 2021

Hepatocellular Carcinoma Trial (DEB-TACE, PVL/PVE+DEB-TACE)

Not yet recruiting
  • Hepatocellular Carcinoma
  • DEB-TACE
  • PVL/PVE+DEB-TACE
  • (no location specified)
Nov 1, 2021

Hepatocellular Carcinoma Non-resectable Trial in Guangzhou (TACE combined with sorafenib/lenvatinib and iodion-125 seeds

Recruiting
  • Hepatocellular Carcinoma Non-resectable
  • TACE combined with sorafenib/lenvatinib and iodion-125 seeds brachytherapy
  • TACE combined with sorafenib/lenvatinib
  • Guangzhou, Guangdong, China
    the Second Affiliated Hospital of Guangzhou Medical University
Jul 27, 2021

TACE in Combination With ICIs for HCC: a Real-world Study

Recruiting
  • Hepatocellular Carcinoma
  • TACE+ICIs
  • TACE
  • Nanjing, China
    Gao-Jun Teng
Jul 22, 2021

Hepatocellular Carcinoma, Portal Vein Occlusion, Tumor Thrombus Trial in Guangzhou (TACE combined with iodine-125 seeds

Active, not recruiting
  • Hepatocellular Carcinoma
  • +2 more
  • TACE combined with iodine-125 seeds implantation
  • TACE
  • Guangzhou, Guangdong, China
    The 2nd Affiliated Hospital of Guangzhou Medical University
Mar 2, 2022

Hepatocellular Carcinoma Trial in Guangzhou (ADCC & TACE, TACE)

Completed
  • Hepatocellular Carcinoma
  • ADCC & TACE
  • TACE
  • Guangzhou, Guangdong, China
    The Third Affiliated Hospital of Sun Yat-sen University
Oct 28, 2020

Hepatocellular Carcinoma Trial in Nanning (DEB-TACE plus Sorafenib, DEB-TACE plus Lenvatinib, DEB-TACE plus PD-1 inhibitor)

Recruiting
  • Hepatocellular Carcinoma
  • DEB-TACE plus Sorafenib
  • +2 more
  • Nanning, Guangxi, China
    Guangxi Medical University Cancer Hospital
Feb 7, 2021

Hepatocellular Carcinoma Trial in Beijing (HAIC, TACE, FOLFOX)

Recruiting
  • Hepatocellular Carcinoma
  • HAIC
  • +4 more
  • Beijing, Beijing, China
    Peking University Cancer Hospital
Jan 10, 2022

Hepatocellular Carcinoma Trial in Liverpool (Nivolumab and TACE/TAE, TACE/TAE)

Recruiting
  • Hepatocellular Carcinoma
  • Nivolumab and TACE/TAE
  • TACE/TAE
  • Liverpool, United Kingdom
    University of Liverpool
Jul 14, 2020

HepatoCellular Carcinoma Trial (Trans-arterial chemoembolization (TACE), TACE with Drug Eluting Beads procedure)

Completed
Has Results
  • HepatoCellular Carcinoma
  • Trans-arterial chemoembolization (TACE)
  • TACE with Drug Eluting Beads procedure
  • (no location specified)
Sep 27, 2020

Hepatocellular Carcinoma, Malignant Tumor Trial in Beijing (TACE plus autologous Tcm immunotherapy, TACE)

Completed
Has Results
  • Hepatocellular Carcinoma
  • Malignant Neoplasm
  • TACE plus autologous Tcm immunotherapy
  • TACE
  • Beijing, Beijing, China
    Cancer Institute and Hospital, Chinese Academy of Medical Scienc
Jun 3, 2020

Hepatocellular Carcinoma Trial in Nanning (procedure, drug, other)

Recruiting
  • Hepatocellular Carcinoma
  • TACE
  • +3 more
  • Nanning, Guangxi, China
    Department of Hepatobilliary Surgery, Affiliated Tumor of Guangx
Jan 7, 2020

Hepatocellular Carcinoma, Face Cancer Trial in Guangzhou (TACE-Sorafenib group, TACE)

Completed
  • Hepatocellular Carcinoma
  • Face Cancer
  • TACE-Sorafenib group
  • TACE
  • Guangzhou, China
    Cancer Centre of Sun Yat-Sen University
Feb 9, 2020

Hepatocellular Carcinoma, Sorafenib, Transarterial Chemoembolization Trial in Guangzhou (TACE+sorafenib, TACE)

Unknown status
  • Hepatocellular Carcinoma
  • +2 more
  • TACE+sorafenib
  • TACE
  • Guangzhou, Guangdong, China
    The First Affiliated Hospital of Sun Yat-sen University
Sep 24, 2019

Hepatocellular Carcinoma Trial in Guangzhou, Kaiping (Lenvatinib, PD-1 antibody, TACE)

Withdrawn
  • Hepatocellular Carcinoma
  • Guangzhou, Guangdong, China
  • +2 more
Apr 30, 2019